Ms. Dorton has served as a member of our board of directors since March 2021. She currently serves as Chief Financial Officer of Nodthera Limited, a company developing medicines to inhibit the NLRP3 inflammasome. She also serves as a member of the board of directors and chair of the audit committee of Fulcrum Therapeutics, Inc. and as a member of the board of directors of US Ecology, Inc. Previously Ms. Dorton has held CFO positions at several biotechnology companies, including Repare Therapeutics Inc., from 2019 through 2020, AVROBIO, Inc., from 2017 through 2018, and Immatics GmbH, from 2015 through 2017. Earlier in her career, Ms. Dorton served as a Managing Director in investment banking for Morgan Stanley and Needham & Company, and as an attorney at Sullivan & Cromwell.
Ms. Dorton received her J.D. from the University of Virginia School of Law, her M.B.A. from George Washington University, and her B.A. from Duke University.